South African Health Products Regulatory Authority
South African regulator under the Medicines and Related Substances Act 101 of 1965; a PIC/S member since 2007 (the first in Africa) that attained WHO Maturity Level 3 for vaccine regulation in 2022.
What this page does not claim
SPEQ curates and cross-references these bodies. It is not affiliated with, accredited by, or endorsed by any of them, and a count of decoded standards is a measure of SPEQ’s coverage, not of a body’s importance.
WHAT SAHPRA COVERS
The South African Health Products Regulatory Authority (SAHPRA) regulates medicines and medical devices under the Medicines and Related Substances Act 101 of 1965 (as amended). It licenses manufacturers and importers, registers medicines, and inspects sites for GMP compliance, applying the PIC/S Guide to Good Manufacturing Practice as its GMP standard. SAHPRA replaced the Medicines Control Council (MCC) in 2018 as a public entity with a broader remit.
WHAT SAHPRA PUBLISHES
- 01The Medicines and Related Substances Act 101 of 1965 and its regulations
- 02SAHPRA licensing, GMP, and registration guidelines
- 03Manufacturer and importer licences and GMP inspection outcomes
- 04Medicine registration decisions and safety communications
- 05Guidance on reliance and international-cooperation pathways
HOW ITS REQUIREMENTS BITE
A manufacturing or import licence is a legal requirement under Act 101 of 1965, conditional on GMP compliance that SAHPRA verifies by inspection against the PIC/S standard. South Africa’s PIC/S membership lets SAHPRA rely on GMP evidence from other member authorities, and its participation in reliance pathways supports registration of products already assessed by trusted regulators — a practical necessity given the volume of imported medicines.
What practitioners get wrong
- SAHPRA (2018) succeeded the Medicines Control Council and inherited its PIC/S membership — the two names refer to the same regulatory lineage.
- SAHPRA applies the PIC/S GMP Guide, so evidence prepared for other PIC/S authorities maps across.
- WHO Maturity Level 3 (2022) signals a stable, well-functioning system; it is a step toward, not the same as, formal WHO-Listed Authority status.
- Reliance pathways are used heavily, so a product assessed by a trusted regulator may reach South African registration faster than a de-novo review.
What an inspection under this authority actually probes
WHERE IT SITS INTERNATIONALLY
South Africa has been a PIC/S participating authority since 1 July 2007 — the first member from Africa — a status SAHPRA carries forward from the Medicines Control Council, so its GMP standard is the PIC/S Guide that mirrors EU GMP. In 2022 SAHPRA attained WHO Maturity Level 3 for vaccine regulation.
SAHPRA STANDARDS SPEQ DECODES · 1
DISCIPLINES IN SAHPRA’S REMIT
SAHPRA: frequently asked questions
Reference answers on South African Health Products Regulatory Authority’s mandate, what it publishes, and how its requirements acquire force.
What law does SAHPRA regulate under?
The Medicines and Related Substances Act 101 of 1965 (as amended), which enables manufacturer and importer licensing, medicine registration, and device regulation, and establishes SAHPRA as the administering authority.
Is South Africa in PIC/S?
Yes. South Africa has been a PIC/S participating authority since 1 July 2007 — the first from Africa — and SAHPRA carries that membership forward from the Medicines Control Council it replaced in 2018.
What is SAHPRA’s WHO maturity status?
In 2022 WHO assessed SAHPRA at Maturity Level 3 for vaccine regulation, indicating a stable, well-functioning, integrated regulatory system. ML3 makes an authority eligible, after further evaluation, for the WHO-Listed Authority list; it is not the same as full listing.